Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 1
2010 4
2011 3
2012 5
2013 3
2014 4
2015 3
2016 2
2017 1
2018 2
2019 2
2020 3
2021 3
2022 6
2023 6
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
Innocenti T, Hanžel J, Truyens M, Lukaš M, Gordon H, Cremer A, Molnár T, Julsgaard M, Onali S, Todeschini A, Nardone OM, Noor NM, Caprioli F, Scaldaferri F, Argyriou K, Savarino EV, Brinar M, Hedin CRH, Vela González M, Armuzzi A, Blesl A, Aratari A, Quadarella A, Parigi TL, Bertani L, Ferracane C, Uzzan M, Michalopoulos G, De Bernardi A, Katsanos K, Balestrieri P, Piñero G, Karmiris K, Casbas AG, Nikolic S, Felice C, Pugliese D, Pastras P, Mocci G, Pouillon L, Mantzaris GJ, Ramos L, Casanova MJ, Koutroubakis IE, García MJ; Jaki-SEQ Study Group; Lobaton T, Dragoni G. Innocenti T, et al. Among authors: aratari a. J Crohns Colitis. 2025 Nov 3:jjaf188. doi: 10.1093/ecco-jcc/jjaf188. Online ahead of print. J Crohns Colitis. 2025. PMID: 41183095
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection.
Goren I, Fallek Boldes O, Boldes T, Knyazev O, Kagramanova A, Limdi JK, Liu E, Sethi-Arora K, Holvoet T, Eder P, Bezzio C, Saibeni S, Vernero M, Alimenti E, Chaparro M, Gisbert JP, Orfanoudaki E, Koutroubakis IE, Pugliese D, Cuccia G, Calviño Suarez C, Ribaldone DG, Veisman I, Sharif K, Festa S, Aratari A, Papi C, Mylonas I, Mantzaris GJ, Truyens M, Lobaton Ortega T, Nancey S, Castiglione F, Nardone OM, Calabrese G, Karmiris K, Velegraki M, Theodoropoulou A, Shitrit AB, Lukas M, Vojtechová G, Ellul P, Bugeja L, Savarino EV, Fischler TS, Dotan I, Yanai H. Goren I, et al. Among authors: aratari a. J Crohns Colitis. 2025 May 8;19(5):jjae161. doi: 10.1093/ecco-jcc/jjae161. J Crohns Colitis. 2025. PMID: 39435855
Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease.
Bezzio C, Franchellucci G, Savarino EV, Mastronardi M, Caprioli FA, Bodini G, Variola A, Scaldaferri F, Furfaro F, Calabrese E, Principi MB, Biscaglia G, Marzo M, Michielan A, Cavalli C, Aratari A, Campigotto M, Ceccarelli L, Cappello M, Saibeni S, Balestrieri P, Soriano A, Casini V, Bertani L, Barberio B, Conforti FS, Danese S, Armuzzi A. Bezzio C, et al. Among authors: aratari a. Crohns Colitis 360. 2024 Oct 24;6(4):otae060. doi: 10.1093/crocol/otae060. eCollection 2024 Oct. Crohns Colitis 360. 2024. PMID: 39525291 Free PMC article. No abstract available.
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study.
Ribaldone DG, Parisio L, Variola A, Bossa F, Castiglione F, Marzo M, Piazza N, Aratari A, Savarino EV, Bodini G, Mastronardi M, Micheli F, Mazzuoli S, Ascolani M, Viganò C, Cappello M, Bezzio C, Ciccocioppo R, Scardino G, Sarli E, Pugliese D, Scaldaferri F, Napolitano D, Todeschini A, Geccherle A, Colaci N, Guerra M, Annese M, Testa A, Caiazzo A, Conforti FS, Festa S, Lorenzon G, Marra A, Magiotta A, Baccini F, Amato A, Poshnjari A, Vernero M, Caprioli F, Caviglia GP; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD). Ribaldone DG, et al. Among authors: aratari a. Dig Liver Dis. 2024 Jan;56(1):77-82. doi: 10.1016/j.dld.2023.07.011. Epub 2023 Jul 19. Dig Liver Dis. 2024. PMID: 37474412
Noninvasive Assessment of Postoperative Disease Recurrence in Crohn's Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease.
Furfaro F, D'Amico F, Zilli A, Craviotto V, Aratari A, Bezzio C, Spinelli A, Gilardi D, Radice S, Saibeni S, Papi C, Peyrin-Biroulet L, Danese S, Fiorino G, Allocca M. Furfaro F, et al. Among authors: aratari a. Clin Gastroenterol Hepatol. 2023 Nov;21(12):3143-3151. doi: 10.1016/j.cgh.2022.11.039. Epub 2022 Dec 12. Clin Gastroenterol Hepatol. 2023. PMID: 36521739
Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
Ribaldone DG, Vieujean S, Julsgaard M, Armandi A, Zingone F, Savarino E, Cañete F, Aratari A, Imperatore N, Ramos L, Plaza R, Pugliese D, Barberio B, Drobne D, Chaparro M. Ribaldone DG, et al. Among authors: aratari a. J Crohns Colitis. 2023 Jul 5;17(7):1097-1102. doi: 10.1093/ecco-jcc/jjad030. J Crohns Colitis. 2023. PMID: 36815684 Free article.
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study.
Dragoni G, Castiglione F, Bezzio C, Pugliese D, Spagnuolo R, Viola A, Cocomazzi F, Aratari A, Savarino EV, Balestrieri P, Onali S, Viganò C, Ribaldone DG, Innocenti T, Testa A, Saibeni S, Privitera G, Milla M, Armuzzi A, Fantini MC, Fiorino G. Dragoni G, et al. Among authors: aratari a. United European Gastroenterol J. 2023 Apr;11(3):271-281. doi: 10.1002/ueg2.12367. Epub 2023 Mar 21. United European Gastroenterol J. 2023. PMID: 36942657 Free PMC article.
50 results